About
Developed by Lifeward (formerly ReWalk Robotics), the ReWalk Personal Exoskeleton became the first FDA-cleared personal exoskeleton for home and community use in 2014. The ReWalk 7 brings updated crutch controls, two customisable walking speeds, and Medicare coverage beginning January 2024, significantly expanding access for eligible users in the United States.
What It Does
The exoskeleton provides powered hip and knee movement, enabling users with T4–L5 spinal cord injuries to stand upright, walk, turn, and ascend and descend stairs using forearm crutches. A wrist-worn smartwatch displays operational modes and alerts, while the MyReWalk companion app supports goal-setting and progress tracking. Structured clinical training is completed before home use begins.
Who It Helps
Adults with spinal cord injury at thoracic or lumbar levels (T4–L5) who want to stand and walk beyond the rehabilitation setting. Regular exoskeleton-assisted walking is associated with reduced pain and spasticity, improved bowel function, better mood and quality of life, and meaningful participation in community life.